| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/05/2000 | EP0968293A1 Staphylococcus 3-dehydroquinate synthase |
| 01/05/2000 | EP0968290A1 Anti-alphavbeta3 humanized monoclonal antibodies |
| 01/05/2000 | EP0968286A1 Growth factor receptor binding protein |
| 01/05/2000 | EP0968276A1 NOVEL clpL |
| 01/05/2000 | EP0968225A1 NOVEL spsB |
| 01/05/2000 | EP0968002A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
| 01/05/2000 | EP0967998A2 Polymeric carrier |
| 01/05/2000 | EP0967997A1 Pharmaceutical composition for eliminating membrane-mediated cell resistance |
| 01/05/2000 | EP0967994A1 Improved method for treatment and diagnosis of il-5 mediated disorders |
| 01/05/2000 | EP0967990A1 UDP-N-ACETYLMURAMOYL-L-AIANINE:D-GLUTAMATE LIGASE (murD) OF STAPHYLOCOCCUS AUREUS |
| 01/05/2000 | EP0967987A1 Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents |
| 01/05/2000 | EP0967977A1 Kit for inhibiting the growth of cancers, comprising a chemotherapeutic agent and a benzimidazole, and optionally a potentiator |
| 01/05/2000 | EP0967976A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock |
| 01/05/2000 | EP0967974A1 Spermicide |
| 01/05/2000 | EP0676206B1 Antimalarial |
| 01/05/2000 | DE19828113A1 Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV Prodrugs of inhibitors of dipeptidyl peptidase IV |
| 01/05/2000 | CN1240347A New aqueous medicament preparations for the production of propellent gas-free aerosols |
| 01/04/2000 | US6011055 Administering indomethacin, naproxen, ibuprofen, tenidap and imiquod in a pharmacologically acceptable carrier, excipient or diluent. |
| 01/04/2000 | US6011051 Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
| 01/04/2000 | US6011022 Topical application of muscarinic analgesic drugs such as neostigmine |
| 01/04/2000 | US6011019 Vasoactive effects and free radical generation by β-amyloid peptides |
| 01/04/2000 | US6010905 Method for inducing monocytes to exhibit the phenotype of activated myeloid dendritic cells |
| 01/04/2000 | US6010878 Interleukin-1 β converting enzyme like apoptotic protease-6 |
| 01/04/2000 | US6010877 cDNA clone HE8CS41 that encodes a novel 7-transmembrane receptor |
| 01/04/2000 | US6010874 Early onset alzheimer's disease gene and gene products |
| 01/04/2000 | US6010848 Screening methods using an atpase protein from hepatitis C virus |
| 01/04/2000 | US6009875 Use of sympathetic antagonists for treatment of chronic muscle pain |
| 01/04/2000 | CA2022848C Process for disinfecting musculoskeletal tissue and tissues prepared thereby |
| 12/30/1999 | DE19828450A1 Use of bisphosphonic acid compounds and autoantigens or allergens |
| 12/30/1999 | DE19827907A1 Synergistic composition for treating infant or adult respiratory distress syndrome |
| 12/30/1999 | CA2244211A1 Novel compounds |
| 12/29/1999 | WO1999067407A2 Transgenetic non-human animal which comprises an inactive peg3 gene, and the use thereof |
| 12/29/1999 | WO1999067384A2 Prostate cancer-associated genes |
| 12/29/1999 | WO1999067278A1 Prodrugs of dipeptidyl peptidase iv inhibitors |
| 12/29/1999 | WO1999066958A2 Use of a compound having affinity for the benzodiazepine mitochondrial receptor in cancer therapy |
| 12/29/1999 | WO1999066951A2 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 12/29/1999 | WO1999066947A1 Adjuvant therapy |
| 12/29/1999 | WO1999066945A1 Compositions and methods for inhibiting bone resorption |
| 12/29/1999 | WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/29/1999 | WO1999066937A1 Erythromycin compositions |
| 12/29/1999 | WO1999066936A1 Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv |
| 12/29/1999 | WO1999066930A1 Compositions and methods for treating elevated blood cholesterol |
| 12/29/1999 | WO1999066926A1 Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ards) and infant respiratory distress syndrome (irds) |
| 12/29/1999 | WO1999066924A1 Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide |
| 12/29/1999 | WO1999066923A1 Application for utility patent for improved enriched platelet wound healant |
| 12/29/1999 | WO1999066919A1 Pharmaceutical composition containing a salt of acetaminophen and at least one other active ingredient |
| 12/29/1999 | WO1999066918A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 12/29/1999 | WO1999066909A2 Method and compositions for the treatment or amelioration of female sexual dysfunction |
| 12/29/1999 | WO1999066875A2 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism |
| 12/29/1999 | WO1999059523A3 Topical pharmaceutical compositions useful for the treatment of cutaneous or circulatory pathologies on inflammatory, immune, proliferative or degenerative basis |
| 12/29/1999 | WO1999057320B1 Antisense modulation of cd40 expression |
| 12/29/1999 | WO1999055339A8 Adenosine a1 receptor antagonist containing composition and method for restoring diuretic and renal function |
| 12/29/1999 | WO1999053910A3 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 12/29/1999 | WO1999049774A3 Methods for the diagnosis and treatment of lung cancer |
| 12/29/1999 | WO1998055150A8 Txu-7-pap immunotoxin and use thereof |
| 12/29/1999 | EP0967284A1 Phosphodiesterases |
| 12/29/1999 | EP0966967A2 Combination therapy of olanzapine (zyprexa) and fluoxetine (prozac) for treatment of bipolar disorder |
| 12/29/1999 | EP0966964A1 Methods for increasing levels of acetylcholine |
| 12/29/1999 | EP0966484A1 Neurotactin and uses therefor |
| 12/29/1999 | EP0966479A1 Polyprolyl inhibitors of cyclophilin |
| 12/29/1999 | EP0966297A1 Methods for regulating gastrointestinal motility |
| 12/29/1999 | EP0966295A1 Calcareous material |
| 12/29/1999 | EP0966292A1 Mononuclear phagocytes and their use to promote axonal regeneration |
| 12/29/1999 | EP0966286A1 Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain |
| 12/29/1999 | EP0966285A1 Use of (+)mefloquine for the treatment of malaria |
| 12/29/1999 | EP0966282A1 Use of angiotensin ii antagonists to treat symptomatic heart failure |
| 12/29/1999 | EP0966274A2 Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase |
| 12/29/1999 | EP0966197A1 Plasmin-depletion therapy |
| 12/29/1999 | EP0774005B1 Surface expression of enzyme in gene directed prodrug therapy |
| 12/29/1999 | CN1240000A Polypeptides encoded by human lipase-like gene, compositions and methods |
| 12/29/1999 | CN1239893A Hormonal composition consisting of oestrogen compound and progestational compound |
| 12/29/1999 | CN1239888A Method for inhibiting stress-activated protein kinases |
| 12/29/1999 | CA2690395A1 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 12/29/1999 | CA2336192A1 Compositions and methods for treating elevated blood cholesterol |
| 12/29/1999 | CA2335992A1 Prodrugs of dipeptidyl peptidase iv inhibitors |
| 12/29/1999 | CA2335858A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 12/29/1999 | CA2335471A1 Compositions and methods for inhibiting bone resorption |
| 12/29/1999 | CA2334973A1 Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide |
| 12/29/1999 | CA2334645A1 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism |
| 12/29/1999 | CA2334550A1 Method and compositions for the treatment or amelioration of female sexual dysfunction |
| 12/29/1999 | CA2333750A1 Adjuvant therapy |
| 12/29/1999 | CA2331769A1 Prostate cancer-associated genes |
| 12/29/1999 | CA2329939A1 Transgenetic non-human animal which comprises an inactive peg3 gene, and the use thereof |
| 12/29/1999 | CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/28/1999 | US6008248 An isotonic mixtures comprising medium-chain triglycerides, vegetable oils and fish oil for treating inflammatory reaction, or an increased risk of vascular thrombosis, or severe cardiac arrythmia |
| 12/28/1999 | US6008221 Method for treating Alzheimer's disease with folic acid |
| 12/28/1999 | US6008050 A polynucleotide encoding a polypeptide related to g protein coupled 7 transmembrane receptors; diagnosis/therapy of heart diseases, osteoporosis, anxiety, eating disorders, schizophrenia, ulcers, parkinson's/huntington's disease |
| 12/28/1999 | US6008042 A polynucleotide; diagnosis and therapy for stroke, septic shock, acquired immune deficiency syndrome, osteoporosis, antiarthritic/antiinflammatory/antiischemic agents, genetic disorders; alzheimer's/parkinson's diseases |
| 12/28/1999 | US6008039 Polynucleotide encoding a novel purinergic P2U receptor |
| 12/28/1999 | US6008033 A herpes simplex virus-2 protease or diisopropylphosphate-liganded herpes simplex virus-2 protease in orthorhombic crystalline form; for computer models and screening for enzyme inhibitors as viricides |
| 12/28/1999 | US6008030 A polynucleotide sequences encoding a protein; therapy and diagnosis of infections, respiratory and gastrointestinal disorders; toxic shock syndrome; antiarthritic and anticarcinogenic agents |
| 12/28/1999 | US6008017 Human cardiac/brain tolloid-like protein |
| 12/28/1999 | US6007841 Effective narcotic agonist-antagonist analgesic potentiated by concurrently administered nontoxic n-methyl-d-aspartate receptor antagonist |
| 12/28/1999 | CA2155169C Process and compositions for activating the differentiation of preadipocyte cells and related therapeutic treatments |
| 12/23/1999 | WO1999066075A2 Diagnostic method based on quantification of extramitochondrial dna |
| 12/23/1999 | WO1999066072A2 Methods for treating a neurological disease by determining bche genotype |
| 12/23/1999 | WO1999066065A2 Proteasomal activity |
| 12/23/1999 | WO1999066060A1 Human mp52 gene promoter and method for exploring useful substance by using the same |
| 12/23/1999 | WO1999066051A2 Nek-related and bub1-related protein kinases |
| 12/23/1999 | WO1999066048A1 A mutant human hepatitis b viral strain and uses thereof |